Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

European Medicines Agency, Scientific Discussion of MabCampath (alemtuzumab)
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity.
A Unified Frequency Domain Model to Study the Effect of Demyelination on Axonal Conduction.
Extensive bilateral lower extremity deep venous thrombosis in a patient on dimethyl fumarate.
Allelic combinations of immune-response genes associated with glatiramer acetate treatment response in Russian multiple sclerosis patients.
Testing the measurement invariance of the University of Washington Self-Efficacy Scale short form across four diagnostic subgroups.
Use of interleukin-2 for management of natalizumab-associated progressive multifocal leukoencephalopathy: case report and review of literature.
Treatment satisfaction in multiple sclerosis.
A benefit-risk analysis of natalizumab in the treatment of patients with multiple sclerosis when considering the risk of progressive multifocal leukoencephalopathy.
'Clinically definite benign multiple sclerosis', an unwarranted conceptual hodgepodge: evidence from a 30-year observational study.
Self-antigen tetramers discriminate between myelin autoantibodies to native or denatured protein.
[The effect of flupirtine, various analgesics and muscle relaxants on skeletal muscle tone in the conscious rat].
Modulation of immune function occurs within hours of therapy initiation for multiple sclerosis.
Biologics-induced autoimmune diseases.
Interferon beta-1b in secondary progressive MS: a combined analysis of the two trials.
New analysis shows Novartis drug Gilenya® significantly reduced rate of brain volume loss across three large Phase III studies
Primary infection with the Epstein-Barr virus and risk of multiple sclerosis.
The cytoskeleton as a novel therapeutic target for old neurodegenerative disorders.
An Exploratory Investigation of Social Stigma and Concealment in Patients with Multiple Sclerosis.
Dimethyl fumarate (BG-12, Tecfidera) - NICE says yes in draft final guidance
SigmaPharm Laboratories Products
Influence of Previous Failed Antispasticity Therapy on the Efficacy and Tolerability of THC:CBD Oromucosal Spray for Multiple Sclerosis Spasticity.
Glatiramer acetate (GA) prevents TNF-α-induced monocyte adhesion to primary endothelial cells through interfering with the NF-κB pathway.
Data supporting the role of Fyn in initiating myelination in the peripheral nervous system.
Magnetic resonance imaging effects of interferon beta-1b in the BENEFIT study: integrated 2-year results.

Pages